Back to Trades
Total Value
$547.2K
Filing Date
Jul 10, 2026
1 transactions
Trade Summary
On Jul 8, 2026, McDonnell Michael R., Director, reported $547.2K of Moderna, Inc. (MRNA) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $73.80. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Moderna, Inc.
- Ticker Symbol
- MRNA
- CIK
- 0001682852
Insider Information
- Role
- Director
- Location
- CAMBRIDGE, MA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001682852-26-000139
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | MRNA derivative | 7,415 | $73.80 | Grant/Award | $547.2K |
| Jul 8, 2026 | MRNA derivative | 1,618 | — | Grant/Award | — |
| Jul 8, 2026 | MRNA derivative | 5,733 | — | Grant/Award | — |
Want live alerts when McDonnell Michael R. trades again?
Download Insider Trades to track MRNA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This option will become fully vested and exercisable on July 8, 2027.
- (F2)Restricted stock units convert into common stock on a one-for-one basis.
- (F3)The shares subject to this restricted stock unit award will vest in full on July 8, 2027.
- (F4)The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.